Intestinal permeability is associated with visceral adiposity in healthy women
- PMID: 21852815
- DOI: 10.1038/oby.2011.251
Intestinal permeability is associated with visceral adiposity in healthy women
Abstract
Increased visceral fat, as opposed to subcutaneous/gluteal, most strongly relates to key metabolic dysfunctions including insulin resistance, hepatic steatosis, and inflammation. Mesenteric fat hypertrophy in patients with Crohn's disease and in experimental rodent models of gut inflammation suggest that impaired gut barrier function with increased leakage of gut-derived antigens may drive visceral lipid deposition. The aim of this study was to determine whether increased intestinal permeability is associated with visceral adiposity in healthy humans. Normal to overweight female subjects were recruited from a population-based cohort. Intestinal permeability was assessed using the ratio of urinary excretion of orally ingested sucralose to mannitol (S/M). In study 1 (n = 67), we found a positive correlation between waist circumference and S/M excretion within a time frame of urine collection consistent with permeability of the lower gastrointestinal tract (6-9 hours post-ingestion; P = 0.022). These results were followed up in study 2 (n = 55) in which we used computed tomography and dual energy X-ray absorptiometry to measure visceral and subcutaneous fat areas of the abdomen, liver fat content, and total body fat of the same women. The S/M ratio from the 6-12 h urine sample correlated with visceral fat area (P = 0.0003) and liver fat content (P = 0.004), but not with subcutaneous or total body fat. This novel finding of an association between intestinal permeability and visceral adiposity and liver fat content in healthy humans suggests that impaired gut barrier function should be further explored as a possible mediator of excess visceral fat accumulation and metabolic dysfunction.
Similar articles
-
Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.J Hepatol. 2012 Aug;57(2):392-8. doi: 10.1016/j.jhep.2012.03.013. Epub 2012 Apr 17. J Hepatol. 2012. PMID: 22521350
-
The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.Int J Obes (Lond). 2006 Jun;30(6):877-83. doi: 10.1038/sj.ijo.0803212. Int J Obes (Lond). 2006. PMID: 16418758
-
Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.Obesity (Silver Spring). 2009 Mar;17(3):424-30. doi: 10.1038/oby.2008.555. Epub 2008 Dec 11. Obesity (Silver Spring). 2009. PMID: 19219061
-
Visceral fat and metabolic inflammation: the portal theory revisited.Obes Rev. 2012 Dec;13 Suppl 2:30-9. doi: 10.1111/j.1467-789X.2012.01035.x. Obes Rev. 2012. PMID: 23107257 Review.
-
Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity.Prog Cardiovasc Dis. 2018 May-Jun;61(1):3-9. doi: 10.1016/j.pcad.2017.12.001. Epub 2017 Dec 8. Prog Cardiovasc Dis. 2018. PMID: 29225114 Review.
Cited by
-
Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges.Nat Metab. 2024 Jul;6(7):1209-1224. doi: 10.1038/s42255-024-01065-0. Epub 2024 Jun 19. Nat Metab. 2024. PMID: 38898236 Review.
-
The Effect of Enteric-Derived Lipopolysaccharides on Obesity.Int J Mol Sci. 2024 Apr 13;25(8):4305. doi: 10.3390/ijms25084305. Int J Mol Sci. 2024. PMID: 38673890 Free PMC article. Review.
-
Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes.Cell Mol Life Sci. 2024 Feb 5;81(1):77. doi: 10.1007/s00018-024-05124-3. Cell Mol Life Sci. 2024. PMID: 38315242 Free PMC article.
-
Precocious infant fecal microbiome promotes enterocyte barrier dysfuction, altered neuroendocrine signaling and associates with increased childhood obesity risk.Gut Microbes. 2024 Jan-Dec;16(1):2290661. doi: 10.1080/19490976.2023.2290661. Epub 2023 Dec 20. Gut Microbes. 2024. PMID: 38117587 Free PMC article.
-
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial.Nutrients. 2023 Oct 2;15(19):4248. doi: 10.3390/nu15194248. Nutrients. 2023. PMID: 37836532 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources